SAC Capital Advisors’s Colgate-Palmolive CL Stock Holding History

SAC Capital Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-47,197	Closed	-$3.06M	–	215
2014 Q1	$3.06M	Buy	47,197 +42,149	+835%	+$2.66M	0.02%	665
2013 Q4	$329K	Sell	5,048 -27,091	-84%	-$1.73M	﹤0.01%	1368
2013 Q3	$1.91M	Sell	32,139 -1,882	-6%	-$112K	0.01%	764
2013 Q2	$1.95M	Buy	+34,021	New	+$2.02M	0.01%	757

Other funds holding CL

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAC Capital Advisors's CL Position: Q2 2014 in Review

SAC Capital Advisors sold out of Colgate-Palmolive (CL) in Q2 2014, closing a stake of 47,197 shares — an estimated $3.06M sold.

SAC Capital Advisors first reported a position in CL in Q2 2013 and held it in 4 quarters. The position peaked at $3.06M in Q1 2014. 1,193 funds tracked by Wall St. Rank hold CL as of Q2 2014.

SAC Capital Advisors reported no remaining Colgate-Palmolive position as of Q2 2014 after selling out during the quarter.
SAC Capital Advisors sold 47,197 Colgate-Palmolive shares in Q2 2014, an estimated $3.06M.
SAC Capital Advisors first reported a position in Colgate-Palmolive in Q2 2013 and held it in 4 quarters.
SAC Capital Advisors's Colgate-Palmolive position peaked at $3.06M in Q1 2014.
1,193 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.